Stryker's 10% post-earnings drop is unwarranted because the numbers were fine. Organic revenue was in line, margins beat, full-year guidance was reiterated and MedSurg is tracking to the high end of its range. Keeping guidance after a cyber incident, despite end-market callouts from Intuitive Surgical and HCA, should be positive. The stock is at its lowest multiple since 2015, derated from over 30x to 18x, with Mako and neurovascular strong; a collapse in hospital buying is the risk. x.com  x.com 

The healthcare utilization scare is a payer problem, not a provider problem, which leaves HCA Healthcare in a strong position. A day after the market sold off insurers on utilization fears, HCA, the country's biggest hospital chain, said at a Wells Fargo conference that demand is growing and 99% of its book is performing as expected. Exchange admissions fell 15%, but that reflects the subsidy cliff rather than weaker demand for care. x.com 

UnitedHealth's insurance model beats hospital operators like HCA because insurers get paid while hospitals see a good chunk of bills never paid or heavily reduced. Members must pay premiums to keep their benefits, and insurers don't pay claims until any deductible is met. That makes UnitedHealth attractive and HCA, along with the REITs that own hospitals, unattractive. x.com 

Stryker's rare double miss looks like quarterly noise, since full-year 2026 guidance is unchanged. Healthcare stocks are widely hated after five years of broken charts from the COVID boom-bust, but fundamentals say otherwise. They are the ultimate safety stocks, and the time to buy them is when no one wants them. x.com